BSE Live
Feb 03, 16:01Prev. Close
625.20
Open Price
613.05
Bid Price (Qty.)
620.00 (2)
Offer Price (Qty.)
629.65 (44)
NSE Live
Feb 03, 15:50Prev. Close
625.55
Open Price
623.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
625.20 (69)
Balance Sheet of Eris Lifesciences (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 13.59 | 13.58 | 13.58 | 13.75 | 13.75 | |
Total Share Capital | 13.59 | 13.58 | 13.58 | 13.75 | 13.75 | |
Reserves and Surplus | 1,904.51 | 1,561.89 | 1,286.12 | 1,142.26 | 854.43 | |
Total Reserves and Surplus | 1,904.51 | 1,561.89 | 1,286.12 | 1,142.26 | 854.43 | |
Total Shareholders Funds | 1,918.11 | 1,575.47 | 1,299.70 | 1,156.01 | 868.18 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 273.69 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 36.79 | 5.80 | 9.85 | 7.25 | 2.88 | |
Long Term Provisions | 28.84 | 29.09 | 24.13 | 16.47 | 15.02 | |
Total Non-Current Liabilities | 65.62 | 34.88 | 33.99 | 23.73 | 291.58 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 96.77 | 86.71 | 89.93 | 74.93 | 79.03 | |
Other Current Liabilities | 31.68 | 30.88 | 29.76 | 196.50 | 115.17 | |
Short Term Provisions | 37.78 | 26.87 | 29.76 | 19.22 | 16.01 | |
Total Current Liabilities | 166.24 | 144.46 | 149.44 | 290.65 | 210.21 | |
Total Capital And Liabilities | 2,150.42 | 1,754.80 | 1,483.13 | 1,470.38 | 1,369.98 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 146.01 | 75.18 | 84.03 | 53.83 | 50.49 | |
Intangible Assets | 495.99 | 509.14 | 516.62 | 430.01 | 439.26 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.75 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 644.99 | 585.88 | 605.01 | 486.58 | 489.75 | |
Non-Current Investments | 678.18 | 480.97 | 246.03 | 274.36 | 451.84 | |
Deferred Tax Assets [Net] | 236.11 | 196.75 | 164.17 | 137.78 | 95.25 | |
Long Term Loans And Advances | 2.82 | 4.95 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 8.32 | 62.63 | 18.33 | 21.88 | 16.95 | |
Total Non-Current Assets | 1,570.41 | 1,331.17 | 1,033.53 | 920.60 | 1,053.79 | |
CURRENT ASSETS | ||||||
Current Investments | 99.55 | 50.40 | 74.27 | 306.11 | 93.76 | |
Inventories | 84.79 | 64.85 | 65.46 | 74.70 | 57.52 | |
Trade Receivables | 137.56 | 113.76 | 140.82 | 75.90 | 60.50 | |
Cash And Cash Equivalents | 46.11 | 32.66 | 64.95 | 6.47 | 8.81 | |
Short Term Loans And Advances | 52.21 | 35.16 | 1.87 | 2.04 | 40.37 | |
OtherCurrentAssets | 159.80 | 126.82 | 102.22 | 84.57 | 55.23 | |
Total Current Assets | 580.01 | 423.63 | 449.60 | 549.78 | 316.19 | |
Total Assets | 2,150.42 | 1,754.80 | 1,483.13 | 1,470.38 | 1,369.98 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 24.34 | 21.21 | 15.81 | 15.29 | 14.12 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 11.14 | 20.10 | 98.27 | 22.99 | 2.78 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 13.44 | 13.44 | 13.44 | 13.61 | 13.61 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.35 | 0.36 | 0.34 | 1.93 | 1.76 | |
Non-Current Investments Unquoted Book Value | 677.83 | 480.61 | 245.69 | 272.43 | 269.85 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 99.55 | 50.40 | 74.27 | 306.11 | 93.76 |
20.01.2023
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y
20.01.2023
Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y
19.01.2023
Market Live: Will nifty hold 18000 amid weak global cues? | IndusInd, Zomato in focus | Opening Bell
18.01.2023
20.01.2023
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y
20.01.2023
Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y
20.10.2022
Eris Life Consolidated September 2022 Net Sales at Rs 460.51 crore, up 28.04% Y-o-Y
20.10.2022
Eris Life Standalone September 2022 Net Sales at Rs 355.37 crore, up 10.14% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher